• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals


43.0000 USD 0.4300 0.99%

As of 20:04:06 ET on 04/16/2014.

Snapshot for Hospira Inc (HSP)

Open: 43.4200 Day's Range: 42.7900 - 43.6000 Volume: 783,651
Previous Close: 43.4300 52wk Range: 30.8600 - 45.2400 1-Yr Rtn: +37.42%

Stock Chart for HSP

No chart data available.
  • HSP:US 43.0000
  • 1D
  • 1M
  • 1Y
Interactive HSP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HSP

Current P/E Ratio (ttm) 27.6125
Estimated P/E(12/2014) 20.2735
Relative P/E vs. SPX 1.6066
Earnings Per Share (USD) (ttm) 1.5573
Est. EPS (USD) (12/2014) 2.1210
Est. PEG Ratio 1.7061
Market Cap (M USD) 7,176.07
Shares Outstanding (M) 166.89
30 Day Average Volume 1,267,551
Price/Book (mrq) 2.4099
Price/Sale (ttm) 1.7791
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HSP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HSP

Hospira, Inc. is a global pharmaceutical and medication delivery company that develops, manufactures and markets products. The Company's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira products are used by hospitals, clinics, home healthcare providers and long-term care facilities.

F Michael Ball "Mike"Chief Executive OfficerDavid John EndicottPres:Medical Devices
Daphne E JonesSenior VP/CIOBrian J SmithSenior VP/Chief Legal Officer
More Company Profile & Key Executives for HSP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil